PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
Retail Label.
Citing DrugCentral © 2024. License
PRECAUTIONS SECTION.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Citing DrugCentral © 2024. License
WARNINGS SECTION.
Ingestion of more than grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
Citing DrugCentral © 2024. License
ADVERSE REACTIONS SECTION.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Citing DrugCentral © 2024. License
BOXED WARNING SECTION.
Accidental overdose of iron-containing products is leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call doctor or poison control center immediately.
Citing DrugCentral © 2024. License
CONTRAINDICATIONS SECTION.
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
Citing DrugCentral © 2024. License
DESCRIPTION SECTION.
CitraNatal Medley(TM) is prescription prenatal/postnatal multi-vitamin/mineral soft gel with Ferr-Ease(R), patented dual-iron delivery comprising both quick release and slow release iron, and DHA, an essential fatty acid. The prenatal vitamin is an oval, purple, opaque soft gel containing greenish-grey liquid to semi-solid fill. The prenatal soft gel is printed 896 in white ink.
Citing DrugCentral © 2024. License
DOSAGE & ADMINISTRATION SECTION.
One prenatal soft gel daily or as directed by physician.
Citing DrugCentral © 2024. License
HOW SUPPLIED SECTION.
Bottles of 30 soft gels each NDC 00178-0896-30.
Citing DrugCentral © 2024. License
INDICATIONS & USAGE SECTION.
CitraNatal Medley is multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
Citing DrugCentral © 2024. License